USPTO serial 88239945
NEXTSEQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 26, 2021
- Examiner
- MAYES, LAURIE ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with NEXTSEQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
San Diego, CA, US
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents, assays, enzymes, chemical preparations all for scientific and research use; biological specimens in the nature of human tissue or human body fluid, animal tissue or animal body fluid for scientific and research use; cultures of microorganisms, plant tissue and nucleotides for scientific and research use, not for medical or veterinary purposes; reagents kits comprised primarily of nucleotides, reagents, enzyme substrates, buffers, chemical preparations, biological preparations in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and also comprised of enzymes for scientific and research use, not for medical or veterinary purposes; nucleotides for medical research; chemical buffer solutions used in analytical chemistry; all of the foregoing related to clinical, genetic and specialized tests related to scientific and clinical diagnostic equipment | ACTIVE | Jan 15, 2014 |
| 005 | Reagents for medical and veterinary use, clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing genetic material; enzymes for medical and veterinary use, nucleotides for medical and veterinary use, buffers for medical and veterinary diagnostic use for testing genetic material, chemical reagents for medical and veterinary use, and biological preparations in the nature of human tissue cultures for medical and veterinary use, human body fluids for medical and veterinary use, animal tissue cultures for medical and veterinary use, and animal body fluids for medical and veterinary use, cultures of microorganisms for medical or veterinary use, and plant tissue for medical and veterinary use in the fields of medical diagnostics, veterinary diagnostics, clinical and diagnostic laboratory medicine, veterinary medicine, and genetics; all of the foregoing related to clinical, genetic and specialized tests related to scientific and clinical diagnostic equipment | ACTIVE | Jan 15, 2014 |
| 009 | Computer hardware and computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; scientific apparatus and instruments, namely, nucleic acid sequencers for laboratory use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics | ACTIVE | Jan 15, 2014 |
| 010 | Clinical and medical diagnostic instruments, namely, nucleic acid sequencers; scientific apparatus and instruments, namely, nucleic acid sequencers for use in medical and veterinary diagnosis and in medical and veterinary treatment | ACTIVE | Jan 15, 2014 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Illumina Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named NEXTSEQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 17, 2021 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Sep 17, 2021 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 17, 2021 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Aug 17, 2020 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Aug 10, 2020 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Aug 10, 2020 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 6, 2020 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 25, 2020 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Mar 18, 2020 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Feb 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 7, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 7, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 7, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 7, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 7, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 21, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 11, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 11, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 11, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 25, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 25, 2018 | NWAP | NEW APPLICATION ENTERED | — |